Hemispherx BioPharma, Inc. (NYSEMKT:HEB)
CAPS Rating:
A biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug entities based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
RSS Headlines
Fool UK
Recs
NOT OPTOMISTIC HERE